PremiumNVO

Novo Nordisk parts ways with HIMS: stock plunges 34%

The Danish pharmaceutical company ended its collaboration with HIMS due to concerns over 'illegal mass production and misleading marketing'.

By the SpyStocks desk · · 2 min read

The rest of this story is for members

The rest is for members

The story continues: the full timeline, the transaction ranges, and the names the forms carry.

Premium comes through the Telegram channel. Already have a code? Sign in to activate it.

Good intel travels.

Share this story

Millions of dollars in CALL options on Moderna

PremiumOption WhalesMRNA6h ago1 min read

Unusual mega dark pool transaction on the S&P 500

PremiumBreaking6h ago1 min read

Microsoft introduces new AI chips and their impact on the market

PremiumBreakingTSM12h ago1 min read